African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians.

J L Kinzie; P H Naylor; M G Nathani; R R Peleman; M N Ehrinpreis; M Lybik; J R Turner; J J Janisse; M Massanari; M G Mutchnick

doi:10.1046/j.1365-2893.2001.00292.x

African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians.

Identifier:nobleid.org/w1/20260515/AF1CEF22

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF1CEF22.svg?ark=w1%2F20260515%2FAF1CEF22)](https://nobleid.org/work/w1/20260515/AF1CEF22)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians.

Identifier:nobleid.org/w1/20260515/AF1CEF22

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF1CEF22.svg?ark=w1%2F20260515%2FAF1CEF22)](https://nobleid.org/work/w1/20260515/AF1CEF22)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work